DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20160365

Levonorgestrel intrauterine contraceptive device in heavy menstrual bleeding: our experience in a tertiary level government hospital

Renuka Malik, Jagrati Gupta, P. Singh, Poonam Yadav

Abstract


Background: The aim of the study was to assess the effect of levonorgestrel intrauterine contraceptive device (LNG-IUCD) on menstrual blood loss and its acceptance in Indian women with Heavy menstrual bleeding (HMB).

Methods: 50 women with HMB and meeting the inclusion criteria were enrolled in the prospective non-randomized observational study from November 2013-2014 in PGIMER, RML HOSPITAL, a tertiary care hospital. LNG-IUCD was inserted and patients were followed up for six months. Reduction in menstrual blood loss, reduction in endometrial thickness, improvement in hemoglobin and serum ferritin and side effects due to LNG-IUCD was noted.

Results: LNG-IUCD was effective in 47 out of 50 patients suffering from HMB. There was 98% reduction in menstrual blood loss (PBAC score) and 67.8% reduction in endometrial thickness after six months. Improvement in hemoglobin was by 2.44 gm/dl whereas serum ferritin improved by 15.39 µg/l after 6 months. Relief in dysmenorrhea was 94.7%. Complete amenorrhea was achieved in 19.14% and 44.6% were suffering from spotting. Treatment failure was seen in 3 patients who expelled LNG-IUCD at varying intervals. One patient with misplaced LNG-IUCD was relieved of symptoms after repositioning. Proper counseling prior to insertion and after insertion made LNG-IUCD well accepted in our study population.

Conclusions: LNG-IUCD is an effective and acceptable non-surgical alternative to a common problem of HMB. The success rate was 94% in our study with only 3 patients needing hysterectomy due to expulsion. Emphasis on counseling patients of troublesome spotting and correct fundal placement is essential.


Keywords


LNG-IUCD, HMB, AUB

Full Text:

PDF

References


Hallberg L, Hogdahl AM, Nilsson L, Rybo G. Menstrual blood loss- a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand. 1966;45:320-51.

Cole SK, Billewicz WZ, Thomson AM. Sources of variation in menstrual blood loss. J Obstet Gynaecol Br Commonw. 1971;78:933-9.

Hallberg L, Hogdahl AM, Nilsson L, Rybo G. Menstrual blood loss and iron deficiency anemia. Acta Med Scand. 1966;180(5):639-50.

National Collaborating Centre for Women’s and Children’s Health. Heavy menstrual bleeding. Available at www.nice.org.uk.http:// www.nice.org.uk/nicemidea/pdf/CG44FullGuidelines.pdf. Published January 2007. Accessed on 26 September 2015.

Coulter A, Peto V, Jenkinson C. Quality of life and patient satisfaction following treatment for menorrhagia. Fam Pract. 1994;11(4):394-401.

National Family Health Survey (NFHS-III), 2005-2006. Available at http://www.nfhsindia.org/pdf/India.pdf. Accessed on 26 September 2015.

Gupta B, Mittal S, Misra R, Deka D, Dadhwal V. Levonorgestrel–releasing intrauterine system vs. transcervical endometrial resection for dysfunctional uterine bleeding. Int J Gynaecol Obstet. 2006;95(3):261-6.

Magon N, Chauhan M, Goel P, Malik S, Kapur K, Kriplani A, et al. Levonorgestrel intrauterine system: current role in management of heavy menstrual bleeding. J Midlife health. 2013;4(1):8-15.

Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. British J Obstet Gynaecol. 1990;97:734-9.

Silverberg SG, Haukkamaa M, Arko H, Nilsson CG, Luukkainen T. Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices. Intern J Gynecol Pathol: Official Journal of the International Society of Gynecological Pathologists. 1986;5:235-41.

Desai R. Efficacy of levonorgestrel releasing intrauterine system for the treatment of menorrhagia due to benign uterine lesions in perimenopausal women. J Midlife Health. 2012;3(1):20-3.

Kriplani A, Singh B.M, Lal S, Agarwal N. Efficacy, acceptability and side effects of the levonorgestrel intrauterine system for menorrhagia. Intern J Gynecol Obstet. 2007;97:190-4.

Chattopdhyay B, Nigam A, Goswami S, Chakravarty P.S. Clinical outcome of Levonorgestrel intra-uterine system in idiopathic menorrhagia. Eur rev med pharmacol sci. 2011;15:764-8.

Kriplani A, Awasthi D, Kulshrestha V, Agarwal N. Efficacy of the levonorgestrel-releasing intrauterine system in uterine leiomyoma. Int J of Gynecol Obstet. 2012;116:35-8.

Murat Naki M, Tekcan C, Ozcan N, Cebi M. Levonorgestrel releasing intrauterine device insertion ameliorates leiomyoma-dependent menorrhagia among women of reproductive age without a significant regression in the uterine and leiomyoma volumes. Fertil Steril. 2010;94(1):371-4.

Shawki O, El-Sherbiny W, Saber W et al. Treatment of heavy menstrual bleeding associated with uterine leiomyoma with the levonorgestrel-releasing intrauterine system. Gynecol Surg. 2009;6(4):331-7.

Magalhães J, Aldrighi JM, de Lima GR. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas. Contraception. 2007;75(3):193-8.

Lockwood C. Mechanism of Normal and Abnormal Endometrial bleeding. Menopause. 2011;18(4):408-11.